599 related articles for article (PubMed ID: 25593033)
21. Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.
Lin CJ; Nasr Z; Premsrirut PK; Porco JA; Hippo Y; Lowe SW; Pelletier J
Cell Rep; 2012 Apr; 1(4):325-33. PubMed ID: 22573234
[TBL] [Abstract][Full Text] [Related]
22. Eukaryotic initiation factor 4F: a vulnerability of tumor cells.
Lee T; Pelletier J
Future Med Chem; 2012 Jan; 4(1):19-31. PubMed ID: 22168162
[TBL] [Abstract][Full Text] [Related]
23. Translational control of cell fate: from integration of environmental signals to breaching anticancer defense.
Bitterman PB; Polunovsky VA
Cell Cycle; 2012 Mar; 11(6):1097-107. PubMed ID: 22356766
[TBL] [Abstract][Full Text] [Related]
24. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.
Gingras AC; Raught B; Sonenberg N
Annu Rev Biochem; 1999; 68():913-63. PubMed ID: 10872469
[TBL] [Abstract][Full Text] [Related]
25. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
[TBL] [Abstract][Full Text] [Related]
26. Targeting the translation machinery in cancer.
Bhat M; Robichaud N; Hulea L; Sonenberg N; Pelletier J; Topisirovic I
Nat Rev Drug Discov; 2015 Apr; 14(4):261-78. PubMed ID: 25743081
[TBL] [Abstract][Full Text] [Related]
27. The Eukaryotic Translation Initiation Factor 4F Complex Restricts Rotavirus Infection via Regulating the Expression of IRF1 and IRF7.
Chen S; Feng C; Fang Y; Zhou X; Xu L; Wang W; Kong X; P Peppelenbosch M; Pan Q; Yin Y
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934842
[TBL] [Abstract][Full Text] [Related]
28. Systemic Reprogramming of Translation Efficiencies on Oxygen Stimulus.
Ho JJD; Wang M; Audas TE; Kwon D; Carlsson SK; Timpano S; Evagelou SL; Brothers S; Gonzalgo ML; Krieger JR; Chen S; Uniacke J; Lee S
Cell Rep; 2016 Feb; 14(6):1293-1300. PubMed ID: 26854219
[TBL] [Abstract][Full Text] [Related]
29. Developing anti-neoplastic biotherapeutics against eIF4F.
Steinberger J; Chu J; Maïga RI; Sleiman K; Pelletier J
Cell Mol Life Sci; 2017 May; 74(9):1681-1692. PubMed ID: 28004147
[TBL] [Abstract][Full Text] [Related]
30. Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F.
Cencic R; Hall DR; Robert F; Du Y; Min J; Li L; Qui M; Lewis I; Kurtkaya S; Dingledine R; Fu H; Kozakov D; Vajda S; Pelletier J
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1046-51. PubMed ID: 21191102
[TBL] [Abstract][Full Text] [Related]
31. CDKAL1 Drives the Maintenance of Cancer Stem-Like Cells by Assembling the eIF4F Translation Initiation Complex.
Huang R; Yamamoto T; Nakata E; Ozaki T; Kurozumi K; Wei F; Tomizawa K; Fujimura A
Adv Sci (Weinh); 2023 Apr; 10(12):e2206542. PubMed ID: 36786012
[TBL] [Abstract][Full Text] [Related]
32. Enhance tumor radiosensitivity by intracellular delivery of eukaryotic translation initiation factor 4E binding proteins.
Tian S; Li XL; Shi M; Yao YQ; Li LW; Xin XY
Med Hypotheses; 2011 Feb; 76(2):246-8. PubMed ID: 21050669
[TBL] [Abstract][Full Text] [Related]
33. Assembly of an active translation initiation factor complex by a viral protein.
Walsh D; Mohr I
Genes Dev; 2006 Feb; 20(4):461-72. PubMed ID: 16481474
[TBL] [Abstract][Full Text] [Related]
34. Translating from cancer to the brain: regulation of protein synthesis by eIF4F.
Kats IR; Klann E
Learn Mem; 2019 Sep; 26(9):332-342. PubMed ID: 31416906
[TBL] [Abstract][Full Text] [Related]
35. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors.
Larsson O; Li S; Issaenko OA; Avdulov S; Peterson M; Smith K; Bitterman PB; Polunovsky VA
Cancer Res; 2007 Jul; 67(14):6814-24. PubMed ID: 17638893
[TBL] [Abstract][Full Text] [Related]
36. Eukaryotic initiation factor 4F-sidestepping resistance mechanisms arising from expression heterogeneity.
Chu J; Ramon Y Cajal S; Sonenberg N; Pelletier J
Curr Opin Genet Dev; 2018 Feb; 48():89-96. PubMed ID: 29169064
[TBL] [Abstract][Full Text] [Related]
37. Regulation of cap-dependent translation initiation in the early stage porcine parthenotes.
Susor A; Jelínková L; Karabínová P; Torner H; Tomek W; Kovárová H; Kubelka M
Mol Reprod Dev; 2008 Dec; 75(12):1716-25. PubMed ID: 18386287
[TBL] [Abstract][Full Text] [Related]
38. A protein that replaces the entire cellular eIF4F complex.
Mir MA; Panganiban AT
EMBO J; 2008 Dec; 27(23):3129-39. PubMed ID: 18971945
[TBL] [Abstract][Full Text] [Related]
39. The plasticity of mRNA translation during cancer progression and therapy resistance.
Fabbri L; Chakraborty A; Robert C; Vagner S
Nat Rev Cancer; 2021 Sep; 21(9):558-577. PubMed ID: 34341537
[TBL] [Abstract][Full Text] [Related]
40. Cellular stress in xenopus kidney cells enhances the phosphorylation of eukaryotic translation initiation factor (eIF)4E and the association of eIF4F with poly(A)-binding protein.
Fraser CS; Pain VM; Morley SJ
Biochem J; 1999 Sep; 342 Pt 3(Pt 3):519-26. PubMed ID: 10477262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
